治疗性超声用于颞下颌关节紊乱疼痛管理:对照与前瞻性研究的系统综述
该系统综述纳入23项研究共1256例参与者,评估治疗性超声对颞下颌关节紊乱(TMD)疼痛及下颌功能的作用。与低强度激光/光生物调节相比多数研究倾向激光更优,但研究数少且方案异质,不能确立激光优于超声。
要点
- 治疗性超声可能作为多模式康复的辅助手段减轻TMD疼痛并改善下颌功能,但证据确定性极低。
- 与低强度激光/光生物调节比较的4项研究倾向激光更优,但研究数少、方案异质,不能确立优劣。
- 连续与脉冲超声模式之间未观察到一致差异,最佳治疗参数仍未确定。
核心结论
- 治疗性超声可能减轻TMD患者疼痛并改善下颌功能,尤其作为多模式康复的辅助手段,但证据确定性对疼痛为极低、对下颌功能/压痛阈值/生活质量为低,不应解读为已确立临床疗效。
研究设计与样本
- 系统综述按PRISMA 2020设计与报告,检索PubMed/MEDLINE、Scopus和Web of Science自建库至2026年4月。
- 纳入随机对照试验、前瞻性临床研究和比较性临床设计,评估治疗性超声对成人TMD疼痛管理的作用。
- 共纳入23项研究、1256例参与者(其中1226例为TMD患者),主要结局为VAS/NRS/VRS评估的疼痛强度和以张口度为主的下颌功能。
- 采用Cochrane RoB 2.0评估随机试验偏倚风险、ROBINS-I评估非随机研究,因临床和方法学异质性大采用叙述性综合而非统计合并。
诊断标准与关键数值
- 一项大型随机试验中,低强度超声治疗后VAS从4.90降至1.70。
- 超声联合家庭锻炼时VAS从42改善至18,而单独锻炼从40改善至26。
- 与低强度激光/光生物调节比较的4项研究倾向激光更优,1项研究倾向低强度超声联合锻炼更优。
- 2项研究显示超声优于TENS,1项研究发现超声、TENS与LLLT之间无有意义的差异;连续与脉冲模式间无一致差异。
临床应用与阅片要点
- 阅读TMD相关康复文献时,需区分组内前后变化与组间治疗效应,避免将基线改善误读为超声疗效。
- 若临床考虑使用治疗性超声,宜作为多模式康复的辅助手段,而非替代低强度激光/光生物调节或TENS的确定优选方案。
- 最佳治疗参数(强度、频率、连续/脉冲模式、疗程)尚未确定,报告时应避免给出具体参数推荐。
局限性
- 因临床和方法学异质性大,未进行统计合并,仅作叙述性综合。
- 疼痛证据确定性为极低,下颌功能、压痛阈值和生活质量/残疾证据确定性为低。
- 仅2/23项研究报告不良事件,干预安全性无法表征。
- 与LLLT/PBM比较的研究数量少且治疗方案异质,相关比较结果需谨慎解读。
- 最佳治疗参数仍未确定,现有证据不能确立临床疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Temporomandibular disorders (TMDs) are a common source of persistent orofacial pain and are estimated to affect a substantial proportion of the population. Therapeutic ultrasound is a non-invasive modality frequently used in musculoskeletal rehabilitation, although its clinical effectiveness for TMD-related pain remains debated. This systematic review was designed and reported in accordance with the PRISMA 2020 recommendations. PubMed/MEDLINE, Scopus, and Web of Science were searched from database inception to April 2026. We included randomized controlled trials, prospective clinical studies, and comparative clinical designs evaluating therapeutic ultrasound for pain management in adults with TMDs. The primary outcomes were pain intensity, assessed using VAS, NRS, or VRS, and mandibular function, assessed mainly by mouth opening. Risk of bias was evaluated using the Cochrane RoB 2.0 tool for randomized trials and ROBINS-I for non-randomized studies. Because of substantial clinical and methodological heterogeneity, findings were synthesized narratively rather than pooled statistically. The search identified 143 records, of which 82 remained after duplicate removal and were screened. Thirty-seven full-text articles were assessed, and 23 studies involving 1256 participants (1226 of them with a temporomandibular disorder) met the eligibility criteria. Twenty-one of 23 studies reported a statistically significant reduction in pain relative to their own baseline; however, these are within-group changes rather than treatment effects, and the certainty of the evidence for pain reduction was very low (GRADE), with low certainty for mandibular function, pressure pain threshold and quality of life/disability. Reported reductions included VAS improvement from 42 to 18 when ultrasound was added to home exercise, compared with 40-26 with exercise alone, and VAS improvement from 4.90 to 1.70 after low-intensity ultrasound therapy in a large randomized trial. Compared with low-level laser therapy or photobiomodulation, four studies favored laser-based treatment, whereas one study favored low-intensity ultrasound combined with exercise. Ultrasound was superior to TENS in two studies, while one study found no meaningful difference among ultrasound, TENS, and LLLT. No consistent difference was observed between continuous and pulsed ultrasound modes. Among randomized trials, 8 studies were judged as low risk of bias, 8 raised some concerns, and 1 was judged as high risk of bias. Adverse events were reported by only 2 of the 23 studies, so the safety of the intervention could not be characterised. Therapeutic ultrasound may reduce pain and improve mandibular function in patients with temporomandibular disorders, particularly as an adjunct to multimodal rehabilitation; however, the certainty of the evidence is very low for pain and low for mandibular function, pressure pain threshold and quality of life/disability, and the optimal treatment parameters remain undetermined. These findings should not be interpreted as establishing clinical efficacy. Although some comparative studies reported greater pain reduction with LLLT/PBM than with ultrasound, this finding should be interpreted cautiously because the number of studies was small and treatment protocols were heterogeneous. Therefore, current evidence does not establish the superiority of LLLT/PBM over therapeutic ultrasound.
引用
- Zhou X, Wang D, Jiang F, et al. Therapeutic Ultrasound for Pain Management in Temporomandibular Disorders: A Systematic Review of Clinical Evidence From Controlled and Prospective Studies. Ultrasound Med Biol. 2026. PMID: 42946581. doi:10.1016/j.ultrasmedbio.2026.09.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。